TF information

TF name: NFE2L2
TF family: TF_bZIP
Ensembl gene ID: ENSG00000116044
Ensembl protein ID: ENSP00000380252, ENSP00000411575, ENSP00000467401, ENSP00000380253, ENSP00000391590
Entrez gene ID: 4780
Database name Link Database name Link
NCBI Gene: Genecards:
Uniprot: Wikipedia:
Cosmic 3D: Geneontology:
CCLE:

Frequency of NFE2L2 in all biosamples
Sample ID Biosample type Tissue type Biosample name TF Frequency
Sample_01_059Cell lineLungPC-90.86666666666667
Sample_02_021Cell lineColonV4290.65897953300663
Sample_02_114Cell lineMammary GlandCAL510.56281407035176
Sample_02_164Cell lineLungH2087_Parental0.13333333333333
Sample_02_179Cell lineUrinary bladderT240.47126436781609
Sample_02_196Cell lineStomachNCC590.14285714285714
Sample_02_205TissueStomachGastric_Primary_Sample_T0.31111111111111
Sample_02_228Cell lineOesophagusKYSE5100.58713886300093
Sample_02_236Cell lineColonV2060.80952380952381
Sample_02_237Cell lineColonV3890.48625069022639
Sample_02_242Cell lineColonV4810.52499519323207
Sample_02_258OtherLungNCI-H1299_EGFP-NEO_reporter_cells_DMSO0.20666666666667
Sample_02_268Cell lineKidneyA-4980.58574856931881
Sample_02_280Cell lineMammary GlandSUM159_DMSO_24h0.4
Sample_02_285Cell lineLiverHuH7_untreat0.087108013937282
Sample_02_299Cell lineNeuroblastomaCLB-MA0.033573141486811
Sample_02_310Cell lineNeuroblastomaSJNB80.14023591087811
Sample_02_313Cell lineNeuroblastomaSK-N-DZ0.1003861003861
Sample_02_322Cell lineColonCaco-20.080753701211306
Sample_02_354Cell lineColonColo2050.37087087087087
Sample_02_358Cell lineColonLS1800.0260663507109
Sample_02_359Cell lineColonColo7410.081325301204819
Sample_02_430Cell lineKidney123642840.25

NFE2L2 distribution in samples’ most representative CRC
Sample ID Tissue type Biosample type Biosample name
Sample_01_059LungCell linePC-9
Sample_02_021ColonCell lineV429
Sample_02_179Urinary bladderCell lineT24
Sample_02_228OesophagusCell lineKYSE510
Sample_02_236ColonCell lineV206
Sample_02_237ColonCell lineV389
Sample_02_268KidneyCell lineA-498

NFE2L2 distribution in all CRCs
Biosample type
Biosample name
Sample ID

Genomic distribution of SEs associated with NFE2L2
Download

Mutation of NFE2L2
Database name Link
gnomAD: gnomAD
ExAC: ExAC
ICGC:
Database name Link
Cosmic:
Cosmic cell lines:
Depmap:

TCGA somatic mutations and clinical variants of NFE2L2

rsID Chr Start Stop Ref Alt Gene_region Gene_symble Effect TCGA_Occurrence
-chr2178095718178095718TGexonicNFE2L2nonsynonymous COAD|1|367|0.00272,COADREAD|1|489|0.00204
-chr2178098800178098800TCexonicNFE2L2nonsynonymous ESCA|1|185|0.00541,KIPAN|1|799|0.00125,KIRP|1|282|0.00355,LIHC|1|373|0.00268
-chr2178098956178098956AGexonicNFE2L2nonsynonymous HNSC|1|512|0.00195
-chr2178098968178098968TAexonicNFE2L2nonsynonymous LUSC|1|178|0.00562
rs765842312chr2178095685178095685CAexonicNFE2L2nonsynonymous COAD|1|367|0.00272,COADREAD|1|489|0.00204
-chr2178096193178096193CGexonicNFE2L2nonsynonymous CESC|1|194|0.00515
rs770882525chr2178096533178096533CGexonicNFE2L2nonsynonymous CESC|1|194|0.00515
-chr2178096314178096314GCexonicNFE2L2nonsynonymous KIPAN|1|799|0.00125,KIRP|1|282|0.00355
rs763240080chr2178095644178095644CTexonicNFE2L2nonsynonymous COAD|1|367|0.00272,COADREAD|1|489|0.00204
-chr2178098809178098809TAexonicNFE2L2nonsynonymous LUAD|1|543|0.00184
rs747179142chr2178096298178096298CTexonicNFE2L2nonsynonymous SKCM|1|368|0.00272
-chr2178096096178096096CAexonicNFE2L2nonsynonymous LUAD|1|543|0.00184
-chr2178095793178095793TAexonicNFE2L2nonsynonymous LUAD|1|543|0.00184
rs775813661chr2178098832178098832GAexonicNFE2L2synonymous COADREAD|1|489|0.00204,READ|1|122|0.00820
-chr2178095854178095854CTexonicNFE2L2nonsynonymous ESCA|1|185|0.00541
-chr2178095961178095961TCexonicNFE2L2nonsynonymous HNSC|1|512|0.00195
-chr2178098928178098928GTexonicNFE2L2nonsynonymous ESCA|1|185|0.00541
-chr2178098944178098944-TexonicNFE2L2frameshift ESCA|1|185|0.00541
-chr2178098957178098957GAexonicNFE2L2nonsynonymous ESCA|1|185|0.00541,HNSC|1|512|0.00195,LUSC|2|178|0.01124
-chr2178095623178095623CTexonicNFE2L2nonsynonymous HNSC|1|512|0.00195
-chr2178098944178098944CGexonicNFE2L2nonsynonymous BLCA|2|396|0.00505,HNSC|1|512|0.00195,LUSC|1|178|0.00562
-chr2178129282178129282GTexonicNFE2L2nonsynonymous TGCT|1|155|0.00645
-chr2178098946178098956ACTTACTCCAA-exonicNFE2L2frameshift BLCA|1|396|0.00253
-chr2178098909178098909AGexonicNFE2L2nonsynonymous ESCA|1|185|0.00541
-chr2178097307178097307GTexonicNFE2L2nonsynonymous COAD|1|367|0.00272,COADREAD|1|489|0.00204
-chr2178098956178098956ACexonicNFE2L2nonsynonymous KIPAN|1|799|0.00125,KIRP|1|282|0.00355
-chr2178095734178095734TGexonicNFE2L2nonsynonymous BLCA|1|396|0.00253
-chr2178098808178098808CAexonicNFE2L2nonsynonymous CESC|1|194|0.00515
-chr2178095822178095822CTexonicNFE2L2synonymous SKCM|1|368|0.00272
-chr2178098804178098804CGexonicNFE2L2nonsynonymous LIHC|1|373|0.00268
-chr2178095480178095480ATUTR3NFE2L2unknown KIPAN|1|799|0.00125,KIRC|1|451|0.00222
-chr2178098801178098801CGexonicNFE2L2nonsynonymous LUAD|1|543|0.00184
-chr2178095546178095546GAexonicNFE2L2synonymous HNSC|1|512|0.00195
-chr2178098936178098936-TACTTCTCGACTexonicNFE2L2nonframeshift -
-chr2178098799178098799TAexonicNFE2L2nonsynonymous BLCA|1|396|0.00253,CESC|1|194|0.00515,CHOL|1|35|0.02857,UCEC|2|248|0.00806
-chr2178098009178098009GCexonicNFE2L2nonsynonymous BRCA|1|982|0.00102
-chr2178095761178095761CGexonicNFE2L2nonsynonymous BLCA|1|396|0.00253
-chr2178098966178098966CAexonicNFE2L2nonsynonymous LIHC|1|373|0.00268
-chr2178098807178098807TGexonicNFE2L2nonsynonymous UCEC|2|248|0.00806
-chr2178098751178098751TGexonicNFE2L2synonymous STAD|1|395|0.00253,STES|1|395|0.00253
-chr2178098968178098968TGexonicNFE2L2nonsynonymous LIHC|1|373|0.00268,LUSC|1|178|0.00562
-chr2178095964178095964CGexonicNFE2L2nonsynonymous HNSC|1|512|0.00195
-chr2178096229178096229CGexonicNFE2L2nonsynonymous CESC|1|194|0.00515
rs749353894chr2178098009178098009GAexonicNFE2L2nonsynonymous COADREAD|1|489|0.00204,READ|1|122|0.00820
-chr2178098975178098975ATexonicNFE2L2nonsynonymous ESCA|1|185|0.00541
-chr2178095660178095660GCexonicNFE2L2synonymous UCS|1|57|0.01754
-chr2178098959178098959TCexonicNFE2L2nonsynonymous LUAD|1|543|0.00184,LUSC|1|178|0.00562
-chr2178098900178098900C-exonicNFE2L2frameshift CESC|1|194|0.00515
-chr2178096691178096691GTexonicNFE2L2nonsynonymous TGCT|1|155|0.00645
-chr2178095532178095532GCexonicNFE2L2nonsynonymous BLCA|1|396|0.00253
-chr2178098973178098973CGexonicNFE2L2nonsynonymous HNSC|2|512|0.00391,LUSC|1|178|0.00562
-chr2178095888178095888GAexonicNFE2L2synonymous CESC|1|194|0.00515
-chr2178095531178095531TCexonicNFE2L2synonymous BRCA|1|982|0.00102
-chr2178098972178098972TAexonicNFE2L2nonsynonymous LIHC|1|373|0.00268
-chr2178096690178096690GTexonicNFE2L2nonsynonymous STAD|1|395|0.00253,STES|1|395|0.00253
rs768430025chr2178096180178096180GAexonicNFE2L2nonsynonymous LUAD|1|543|0.00184
-chr2178098803178098803CGexonicNFE2L2nonsynonymous BLCA|1|396|0.00253,LIHC|1|373|0.00268
-chr2178098816178098816CGexonicNFE2L2nonsynonymous CESC|1|194|0.00515
-chr2178096372178096372GCexonicNFE2L2nonsynonymous BRCA|1|982|0.00102
-chr2178098862178098862TGexonicNFE2L2nonsynonymous LIHC|1|373|0.00268
-chr2178096090178096090CTexonicNFE2L2nonsynonymous LUAD|1|543|0.00184
-chr2178098807178098807TCexonicNFE2L2nonsynonymous HNSC|1|512|0.00195
-chr2178095799178095799GAexonicNFE2L2nonsynonymous COADREAD|1|489|0.00204,READ|1|122|0.00820
-chr2178097253178097269GGGCTCTCGATGTGACC-exonicNFE2L2frameshift -
rs746016111chr2178096082178096082CTexonicNFE2L2nonsynonymous BLCA|1|396|0.00253
rs181294188chr2178095985178095985CTexonicNFE2L2nonsynonymous UCEC|1|248|0.00403
rs372010034chr2178095651178095651TCexonicNFE2L2synonymous PCPG|1|184|0.00543
-chr2178098803178098803CTexonicNFE2L2nonsynonymous BRCA|3|982|0.00305,KIPAN|1|799|0.00125,KIRC|1|451|0.00222
-chr2178098968178098968TCexonicNFE2L2nonsynonymous LIHC|1|373|0.00268,LUAD|1|543|0.00184
-chr2178098961178098974TATATCTTGCCTCC-exonicNFE2L2frameshift LIHC|1|373|0.00268
-chr2178098950178098950ACexonicNFE2L2nonsynonymous HNSC|1|512|0.00195
-chr2178096727178096727-AexonicNFE2L2frameshift HNSC|1|512|0.00195
-chr2178098912178098912CTexonicNFE2L2nonsynonymous ESCA|1|185|0.00541
-chr2178098806178098806GTexonicNFE2L2nonsynonymous KIPAN|1|799|0.00125,KIRP|1|282|0.00355,LUSC|1|178|0.00562
-chr2178097233178097233GCexonicNFE2L2nonsynonymous BLCA|1|396|0.00253
-chr2178098803178098803CAexonicNFE2L2nonsynonymous KIPAN|1|799|0.00125,KIRP|1|282|0.00355,LUSC|1|178|0.00562,UCEC|1|248|0.00403
-chr2178098806178098806GAexonicNFE2L2nonsynonymous BLCA|1|396|0.00253,LIHC|1|373|0.00268
-chr2178095836178095836GAexonicNFE2L2nonsynonymous UCEC|1|248|0.00403
-chr2178098815178098815TCexonicNFE2L2nonsynonymous LUSC|1|178|0.00562
-chr2178095740178095740GAexonicNFE2L2nonsynonymous UCS|1|57|0.01754
-chr2178098966178098966CGexonicNFE2L2nonsynonymous LUAD|1|543|0.00184,LUSC|1|178|0.00562
-chr2178098806178098806GCexonicNFE2L2nonsynonymous UCEC|1|248|0.00403
-chr2178098800178098800TGexonicNFE2L2nonsynonymous ESCA|1|185|0.00541
-chr2178098969178098969GTexonicNFE2L2nonsynonymous UCEC|1|248|0.00403
-chr2178098936178098937AT-exonicNFE2L2frameshift LUSC|1|178|0.00562
-chr2178096052178096052CAexonicNFE2L2stopgain KIPAN|1|799|0.00125,KIRC|1|451|0.00222
-chr2178096252178096252GTexonicNFE2L2stopgain UVM|1|80|0.01250
-chr2178096114178096114GAexonicNFE2L2nonsynonymous SKCM|1|368|0.00272
-chr2178096545178096545GCexonicNFE2L2nonsynonymous HNSC|1|512|0.00195
-chr2178095969178095969GAexonicNFE2L2synonymous HNSC|1|512|0.00195
-chr2178096592178096592GAexonicNFE2L2nonsynonymous KIPAN|2|799|0.00250,KIRC|2|451|0.00443
-chr2178098944178098944CTexonicNFE2L2nonsynonymous CESC|1|194|0.00515,LUSC|3|178|0.01685
-chr2178095920178095920CGexonicNFE2L2nonsynonymous CESC|1|194|0.00515
-chr2178097218178097218CAexonicNFE2L2stopgain CESC|1|194|0.00515
-chr2178096113178096113GAexonicNFE2L2synonymous SKCM|1|368|0.00272
-chr2178098962178098962AGexonicNFE2L2nonsynonymous HNSC|2|512|0.00391,PAAD|1|185|0.00541
-chr2178098961178098961TCexonicNFE2L2nonsynonymous LIHC|1|373|0.00268
-chr2178095817178095817CTexonicNFE2L2nonsynonymous SKCM|1|368|0.00272
-chr2178097223178097223GCexonicNFE2L2stopgain GBMLGG|1|820|0.00122,LGG|1|530|0.00189
-chr2178095787178095787CGexonicNFE2L2nonsynonymous CESC|1|194|0.00515
-chr2178098953178098953CGexonicNFE2L2nonsynonymous BLCA|1|396|0.00253,ESCA|1|185|0.00541,LUSC|2|178|0.01124
-chr2178098945178098945GCexonicNFE2L2nonsynonymous BLCA|5|396|0.01263,ESCA|1|185|0.00541,HNSC|1|512|0.00195,KIPAN|1|799|0.00125,KIRC|1|451|0.00222,LUSC|1|178|0.00562,UCEC|2|248|0.00806
-chr2178098975178098975AGexonicNFE2L2nonsynonymous BLCA|1|396|0.00253,HNSC|1|512|0.00195,LUAD|1|543|0.00184
-chr2178096428178096428TGexonicNFE2L2synonymous BRCA|1|982|0.00102
-chr2178096193178096193CAexonicNFE2L2stopgain COADREAD|1|489|0.00204,READ|1|122|0.00820
-chr2178097980178097980CGexonicNFE2L2nonsynonymous CESC|1|194|0.00515
-chr2178098960178098960CAexonicNFE2L2nonsynonymous BLCA|1|396|0.00253,CESC|1|194|0.00515,HNSC|1|512|0.00195,LUSC|1|178|0.00562
-chr2178095665178095665-TexonicNFE2L2frameshift SKCM|1|368|0.00272
-chr2178098809178098809TCexonicNFE2L2nonsynonymous ESCA|1|185|0.00541
-chr2178098960178098960CTexonicNFE2L2nonsynonymous LUSC|1|178|0.00562
-chr2178098810178098810CTexonicNFE2L2nonsynonymous BLCA|2|396|0.00505,CESC|1|194|0.00515,ESCA|1|185|0.00541,HNSC|4|512|0.00781
-chr2178098954178098954CTexonicNFE2L2nonsynonymous BLCA|1|396|0.00253,LUAD|1|543|0.00184
-chr2178098960178098960-ATexonicNFE2L2frameshift ESCA|1|185|0.00541
-chr2178098888178098888TGexonicNFE2L2nonsynonymous BLCA|1|396|0.00253
-chr2178098920178098942CGCTGACTGAAGTCAAATACTTC-exonicNFE2L2frameshift LUAD|1|543|0.00184
-chr2178098804178098804CAexonicNFE2L2nonsynonymous HNSC|1|512|0.00195,LIHC|1|373|0.00268
-chr2178098810178098810CGexonicNFE2L2nonsynonymous BLCA|1|396|0.00253,ESCA|2|185|0.01081,HNSC|4|512|0.00781,LUSC|4|178|0.02247
-chr2178098960178098960CGexonicNFE2L2nonsynonymous BLCA|2|396|0.00505,CESC|2|194|0.01031,ESCA|1|185|0.00541,HNSC|5|512|0.00977,KIPAN|1|799|0.00125,KIRC|1|451|0.00222,LUAD|1|543|0.00184,LUSC|2|178|0.01124,UCEC|1|248|0.00403
-chr2178097915178097915ACintronicNFE2L2unknown UCEC|1|248|0.00403
-chr2178096565178096565TCexonicNFE2L2nonsynonymous PRAD|1|499|0.00200
-chr2178098962178098963AT-exonicNFE2L2frameshift LIHC|1|373|0.00268
-chr2178097235178097235TCexonicNFE2L2nonsynonymous UCEC|1|248|0.00403
-chr2178098804178098804CTexonicNFE2L2nonsynonymous ESCA|1|185|0.00541,LUSC|2|178|0.01124
-chr2178095977178095977CTexonicNFE2L2nonsynonymous STAD|1|395|0.00253,STES|1|395|0.00253
-chr2178098810178098810CAexonicNFE2L2stopgain LUAD|1|543|0.00184
-chr2178129392178129399GCGGCGGC-UTR5NFE2L2unknown SARC|1|247|0.00405
-chr2178098956178098956ATexonicNFE2L2nonsynonymous HNSC|1|512|0.00195,KIPAN|1|799|0.00125,KIRC|1|451|0.00222
-chr2178098800178098800TAexonicNFE2L2nonsynonymous HNSC|1|512|0.00195
-chr2178098918178098918GCexonicNFE2L2nonsynonymous UCEC|1|248|0.00403
-chr2178095647178095647GAexonicNFE2L2nonsynonymous HNSC|1|512|0.00195,PCPG|1|184|0.00543
-chr2178098937178098944TACTTCTC-exonicNFE2L2frameshift LUAD|1|543|0.00184
-chr2178098799178098799TGexonicNFE2L2nonsynonymous KIPAN|2|799|0.00250,KIRC|1|451|0.00222,KIRP|1|282|0.00355,LIHC|1|373|0.00268,LUAD|1|543|0.00184

Disease information of NFE2L2
TF_name Disease_name Disease_class Disease_semantic_type TF_disease_source
NFE2L2 Malignant neoplasm of skin C04;C17 Neoplastic Process CTD_human
NFE2L2 Non-Small Cell Lung Carcinoma C04;C08 Neoplastic Process CGI;CTD_human
NFE2L2 Squamous cell carcinoma C04 Neoplastic Process CTD_human
NFE2L2 Cholestasis C06 Disease or Syndrome CTD_human
NFE2L2 Diabetic Nephropathy C12;C13;C19 Disease or Syndrome CTD_human
NFE2L2 Drug toxicity C25 Injury or Poisoning CTD_human
NFE2L2 Pathological accumulation of air in tissues C23 Pathologic Function CTD_human
NFE2L2 Experimental Autoimmune Encephalomyelitis C10;C20 Experimental Model of Disease CTD_human
NFE2L2 Endometrial Neoplasms C04;C13 Neoplastic Process CTD_human
NFE2L2 Fatty Liver C06 Disease or Syndrome CTD_human
NFE2L2 Gastrointestinal Diseases C06 Disease or Syndrome CTD_human
NFE2L2 Nodular glomerulosclerosis C12;C13;C19 Disease or Syndrome CTD_human
NFE2L2 Heart failure C14 Disease or Syndrome CTD_human
NFE2L2 Congestive heart failure C14 Disease or Syndrome CTD_human
NFE2L2 Hepatitis, Toxic C06;C25 Injury or Poisoning CTD_human
NFE2L2 Hyperglycemia C18 Disease or Syndrome CTD_human
NFE2L2 Hyperplasia C23 Pathologic Function CTD_human
NFE2L2 Keratosis C17 Disease or Syndrome CTD_human
NFE2L2 Keratosis Blennorrhagica C17 Disease or Syndrome CTD_human
NFE2L2 Kidney Diseases C12;C13 Disease or Syndrome CTD_human
NFE2L2 Kidney Failure, Acute C12;C13 Disease or Syndrome CTD_human
NFE2L2 Left-Sided Heart Failure C14 Disease or Syndrome CTD_human
NFE2L2 Liver Cirrhosis C06 Disease or Syndrome CTD_human
NFE2L2 Liver Cirrhosis, Experimental C06 Experimental Model of Disease CTD_human
NFE2L2 Liver neoplasms C04;C06 Neoplastic Process CTD_human
NFE2L2 Necrosis C23 Organ or Tissue Function CTD_human
NFE2L2 Prostatic Neoplasms C04;C12 Neoplastic Process CTD_human
NFE2L2 Pulmonary Fibrosis C08 Disease or Syndrome CTD_human
NFE2L2 Skin Neoplasms C04;C17 Neoplastic Process CTD_human
NFE2L2 Adverse reaction to drug C25 Pathologic Function CTD_human
NFE2L2 Ovarian Failure, Premature C13;C19 Disease or Syndrome CTD_human
NFE2L2 Hamman-Rich syndrome C08 Disease or Syndrome CTD_human
NFE2L2 Gonadotropin-Resistant Ovary Syndrome C13;C19 Disease or Syndrome CTD_human
NFE2L2 Keratoma C17 Acquired Abnormality CTD_human
NFE2L2 Encephalopathy, Toxic C10;C25 Injury or Poisoning CTD_human
NFE2L2 Adenocarcinoma of lung (disorder) C04;C08 Neoplastic Process CTD_human
NFE2L2 Toxic Encephalitis C10;C25 Injury or Poisoning CTD_human
NFE2L2 Dermatitis, Allergic Contact C17;C20 Disease or Syndrome CTD_human
NFE2L2 Vascular System Injuries C14;C26 Injury or Poisoning CTD_human
NFE2L2 Neurotoxicity Syndromes C10;C25 Injury or Poisoning CTD_human
NFE2L2 Heart Failure, Right-Sided C14 Disease or Syndrome CTD_human
NFE2L2 Fibrosis, Liver C06 Disease or Syndrome CTD_human
NFE2L2 Acute Lung Injury C08 Injury or Poisoning CTD_human
NFE2L2 Squamous cell carcinoma of esophagus C04;C06 Neoplastic Process CTD_human
NFE2L2 Chromosome Breaks C23 Cell or Molecular Dysfunction CTD_human
NFE2L2 Malignant neoplasm of liver C04;C06 Neoplastic Process CTD_human
NFE2L2 Malignant neoplasm of prostate C04;C12 Neoplastic Process CTD_human
NFE2L2 Chromosome Breakage C23 Cell or Molecular Dysfunction CTD_human
NFE2L2 Non-alcoholic Fatty Liver Disease C06 Disease or Syndrome CTD_human
NFE2L2 Endometrial Carcinoma C04;C13 Neoplastic Process CTD_human
NFE2L2 Functional Gastrointestinal Disorders C06 Disease or Syndrome CTD_human
NFE2L2 Carcinogenesis C04;C23 Neoplastic Process CTD_human
NFE2L2 Drug-Induced Liver Disease C06;C25 Disease or Syndrome CTD_human
NFE2L2 Carcinoma, Pancreatic Ductal C04;C06;C19 Neoplastic Process CTD_human
NFE2L2 Squamous cell carcinoma of the head and neck C04 Neoplastic Process CGI
NFE2L2 Hepatitis, Drug-Induced C06;C25 Disease or Syndrome CTD_human
NFE2L2 Cholera Infantum C06 Disease or Syndrome CTD_human
NFE2L2 Acute Kidney Insufficiency C12;C13 Disease or Syndrome CTD_human
NFE2L2 Hyperglycemia, Postprandial C18 Finding CTD_human
NFE2L2 Myocardial Failure C14 Disease or Syndrome CTD_human
NFE2L2 Heart Decompensation C14 Pathologic Function CTD_human
NFE2L2 Liver carcinoma C04;C06 Neoplastic Process CTD_human
NFE2L2 Acute kidney injury C12;C13 Injury or Poisoning CTD_human
NFE2L2 Steatohepatitis C06 Disease or Syndrome CTD_human
NFE2L2 Nonalcoholic Steatohepatitis C06 Disease or Syndrome CTD_human
NFE2L2 Hypergonadotropic Ovarian Failure, X-Linked C10;C13;C16;C19 Disease or Syndrome CTD_human
NFE2L2 Drug-Induced Acute Liver Injury C06;C25 Disease or Syndrome CTD_human
NFE2L2 Chemical and Drug Induced Liver Injury C06;C25 Disease or Syndrome CTD_human
NFE2L2 Chemically-Induced Liver Toxicity C06;C25 Disease or Syndrome CTD_human

Pathway associated with NFE2L2
pathway_ID pathway_name pathway_source gene_number edge_number
pathway0002579 Protein processing in endoplasmic reticulum kegg 166 1160
pathway0002756 Hs_Photodynamic_therapy-induced_unfolded_protein_response_WP3613_89330 wikipathways 6 6
pathway0002777 Hs_Transcriptional_activation_by_NRF2_WP3_79527 wikipathways 6 7

Go term information of NFE2L2
GO_term_name GO_term_type TF_name
GO_NEGATIVE_REGULATION_OF_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES BP NFE2L2
GO_REGULATION_OF_ENDOTHELIAL_CELL_APOPTOTIC_PROCESS BP NFE2L2
GO_REGULATION_OF_COAGULATION BP NFE2L2
GO_RESPONSE_TO_FLUID_SHEAR_STRESS BP NFE2L2
GO_NEGATIVE_REGULATION_OF_STEM_CELL_DIFFERENTIATION BP NFE2L2
GO_CELLULAR_RESPONSE_TO_FLUID_SHEAR_STRESS BP NFE2L2
GO_POSITIVE_REGULATION_OF_COAGULATION BP NFE2L2
GO_NEGATIVE_REGULATION_OF_RESPONSE_TO_OXIDATIVE_STRESS BP NFE2L2
GO_CELLULAR_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND BP NFE2L2
GO_POSITIVE_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS BP NFE2L2
GO_RESPONSE_TO_INORGANIC_SUBSTANCE BP NFE2L2
GO_REGULATION_OF_HYDROGEN_PEROXIDE_INDUCED_CELL_DEATH BP NFE2L2
GO_NEGATIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION BP NFE2L2
GO_REGULATION_OF_REMOVAL_OF_SUPEROXIDE_RADICALS BP NFE2L2
GO_NEGATIVE_REGULATION_OF_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION BP NFE2L2
GO_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY BP NFE2L2
GO_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS BP NFE2L2
GO_ER_NUCLEUS_SIGNALING_PATHWAY BP NFE2L2
GO_REGULATION_OF_CATABOLIC_PROCESS BP NFE2L2
GO_CELL_REDOX_HOMEOSTASIS BP NFE2L2
GO_CELLULAR_RESPONSE_TO_HYDROGEN_PEROXIDE BP NFE2L2
GO_NEGATIVE_REGULATION_OF_HEMOPOIESIS BP NFE2L2
GO_POSITIVE_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_STRESS BP NFE2L2
GO_POSITIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS BP NFE2L2
GO_RESPONSE_TO_EXTRACELLULAR_STIMULUS BP NFE2L2
GO_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS BP NFE2L2
GO_POSITIVE_REGULATION_OF_GLUCOSE_TRANSPORT BP NFE2L2
GO_POSITIVE_REGULATION_OF_RESPONSE_TO_WOUNDING BP NFE2L2
GO_REGULATION_OF_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION BP NFE2L2
GO_PERK_MEDIATED_UNFOLDED_PROTEIN_RESPONSE BP NFE2L2
GO_CELLULAR_RESPONSE_TO_STARVATION BP NFE2L2
GO_POSITIVE_REGULATION_OF_WOUND_HEALING BP NFE2L2
GO_REGULATION_OF_SUPEROXIDE_METABOLIC_PROCESS BP NFE2L2
GO_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_CELL_DEATH BP NFE2L2
GO_CELLULAR_RESPONSE_TO_GLUCOSE_STARVATION BP NFE2L2
GO_REGULATION_OF_RESPONSE_TO_OXIDATIVE_STRESS BP NFE2L2
GO_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_APOPTOTIC_PROCESS BP NFE2L2
GO_REGULATION_OF_SULFUR_METABOLIC_PROCESS BP NFE2L2
GO_POSITIVE_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_INVOLVED_IN_CELLULAR_RESPONSE_TO_CHEMICAL_STIMULUS BP NFE2L2
GO_NEGATIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY BP NFE2L2
GO_REGULATION_OF_ERAD_PATHWAY BP NFE2L2
GO_CELLULAR_RESPONSE_TO_DRUG BP NFE2L2
GO_CELLULAR_RESPONSE_TO_OXIDATIVE_STRESS BP NFE2L2
GO_RESPONSE_TO_LAMINAR_FLUID_SHEAR_STRESS BP NFE2L2
GO_RESPONSE_TO_TOPOLOGICALLY_INCORRECT_PROTEIN BP NFE2L2
GO_POSITIVE_REGULATION_OF_ERAD_PATHWAY BP NFE2L2
GO_RESPONSE_TO_HYDROGEN_PEROXIDE BP NFE2L2
GO_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY BP NFE2L2
GO_REGULATION_OF_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES BP NFE2L2
GO_REGULATION_OF_STEM_CELL_DIFFERENTIATION BP NFE2L2
GO_PROTEIN_DNA_COMPLEX CC NFE2L2
GO_TRANSCRIPTIONAL_ACTIVATOR_ACTIVITY_RNA_POLYMERASE_II_DISTAL_ENHANCER_SEQUENCE_SPECIFIC_BINDING MF NFE2L2
GO_TRANSCRIPTION_FACTOR_ACTIVITY_RNA_POLYMERASE_II_DISTAL_ENHANCER_SEQUENCE_SPECIFIC_BINDING MF NFE2L2
GO_TRANSCRIPTION_COFACTOR_BINDING MF NFE2L2
GO_ACTIVATING_TRANSCRIPTION_FACTOR_BINDING MF NFE2L2
GO_RNA_POLYMERASE_II_ACTIVATING_TRANSCRIPTION_FACTOR_BINDING MF NFE2L2
GO_RNA_POLYMERASE_II_DISTAL_ENHANCER_SEQUENCE_SPECIFIC_DNA_BINDING MF NFE2L2

Survival analysis of NFE2L2



Calculate the hazards ratio based on Cox PH Model.
Add the 95% CI as dotted line.

Expression of NFE2L2